Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ADRB1 anticorps (Internal Region)

Verified ADRB1 Reactivité: Humain ELISA, IHC, IF Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN185584
  • Antigène Voir toutes ADRB1 Anticorps
    ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
    Épitope
    • 16
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reactivité
    • 41
    • 27
    • 26
    • 5
    • 5
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 43
    Chèvre
    Clonalité
    • 43
    Polyclonal
    Conjugué
    • 13
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ADRB1 est non-conjugé
    Application
    • 31
    • 18
    • 13
    • 13
    • 10
    • 6
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Fonction
    ADRB1
    Séquence
    ESDEARRCYN DPK
     Réactivité croisée
    Chien, Humain, Souris, Rat
    Purification
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Classe de qualité
    Verified
    Immunogène
    Peptide with sequence ESDEARRCYNDPK, from the internal region of the protein sequence according to NP_000675.1.
    Isotype
    IgG
  • Indications d'application

    Immunohistochemistry: Paraffin embedded Human Heart. Recommended concentration: 6 μg/mL.

    Western Blot: This antibody is not recommended for use in Western blotting.

    Peptide ELISA: antibody detection limit dilution 1:2000.

    Commentaires

    Immunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10μg/ml.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Minimize freezing and thawing.
    Stock
    -20 °C
    Stockage commentaire
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Wenzel, Schulze-Rothe, Müller, Wallukat, Haberland: "Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology." dans: PLoS ONE, Vol. 13, Issue 2, pp. e0192615, (2018) (PubMed).

    Wallukat, Prüss, Müller, Schimke: "Functional autoantibodies in patients with different forms of dementia." dans: PLoS ONE, Vol. 13, Issue 3, pp. e0192778, (2018) (PubMed).

    Wenzel, Schulze-Rothe, Haberland, Müller, Wallukat, Davideit: "Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy." dans: Heliyon, Vol. 3, Issue 7, pp. e00362, (2017) (PubMed).

    Wallukat, Haberland, Berg, Schulz, Freyse, Dahmen, Kage, Dandel, Vetter, Salzsieder, Kreutz, Schimke: "The first aptamer-apheresis column specifically for clearing blood of ?1-receptor autoantibodies." dans: Circulation journal : official journal of the Japanese Circulation Society, Vol. 76, Issue 10, pp. 2449-55, (2012) (PubMed).

    Haberland, Wallukat, Dahmen, Kage, Schimke: "Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies." dans: Circulation research, Vol. 109, Issue 9, pp. 986-92, (2011) (PubMed).

    Wallukat, Muñoz Saravia, Haberland, Bartel, Araujo, Valda, Duchen, Diaz Ramirez, Borges, Schimke: "Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients." dans: Journal of the American College of Cardiology, Vol. 55, Issue 5, pp. 463-8, (2010) (PubMed).

  • Antigène
    ADRB1 (Adrenergic, beta-1-, Receptor (ADRB1))
    Autre désignation
    ADRB1 (ADRB1 Produits)
    Synonymes
    anticorps ADRB1R, anticorps B1AR, anticorps BETA1AR, anticorps RHR, anticorps RATB1AR, anticorps X-Beta1AR, anticorps BAR1, anticorps zgc:194728, anticorps zgc:194731, anticorps ADRB1, anticorps Adrb-1, anticorps beta-AR, anticorps adrenoceptor beta 1, anticorps adrenoceptor beta 1 L homeolog, anticorps adrenergic, beta-1-, receptor, anticorps adrenergic receptor, beta 1, anticorps ADRB1, anticorps Adrb1, anticorps adrb1.L, anticorps adrb1
    Sujet
    ADRB1, adrenergic, beta-1-, receptor, ADRB1R, B1AR, BETA1AR, RHR, beta-1-adrenergic receptor
    Poids moléculaire
    51.2kDa
    ID gène
    153
    NCBI Accession
    NP_000675
    Pathways
    cAMP Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Brown Fat Cell Differentiation
Vous êtes ici:
Support technique